Queensland Lung Cancer Screening Study: rationale, design and methods

• Published in: Internal medicine journal 2013-02, Vol.43 (2), p.174-182
• Main Authors: Marshall, H. M., Bowman, R. V., Crossin, J., Lau, M. A., Slaughter, R. E., Passmore, L. H., McCaul, E. M., Courtney, D. A., Windsor, M. N., Yang, I. A., Smith, I. R., Keir, B. J., Hayes, T. J., Redmond, S. J., Zimmerman, P. V., Fong, K. M.
• Format: Article
• Language: English
• Subjects: Aged; Cancer; Diagnosis; Early Detection of Cancer - methods; Early Detection of Cancer - standards; Feasibility Studies; Female; Humans; Low-dose computed tomography; Lung Neoplasms - diagnostic imaging; Lung Neoplasms - epidemiology; lung neoplasms/radiography; Male; mass screening; Middle Aged; Prospective Studies; Queensland - epidemiology; radiography; Risk Factors; Smoking; thoracic; tomography; Tomography, X-Ray Computed - methods; Tomography, X-Ray Computed - standards; X-ray computed/adverse effect; X-ray computed/method
• ISSN: 1444-0903; 1445-5994
• DOI: 10.1111/j.1445-5994.2012.02789.x

Background Lung cancer is the leading cause of cancer‐related mortality in Australia. Screening using low‐dose computed tomography (LDCT) can reduce lung cancer mortality. The feasibility of screening in Australia is unknown. This paper describes the rationale, design and methods of the Queensland Lung Cancer Screening Study. Aims The aim of the study is to describe the methodology for a feasibility study of lung cancer screening by LDCT in Australia. Methods The Queensland Lung Cancer Screening Study is an ongoing, prospective observational study of screening by LDCT at a single tertiary institution. Healthy volunteers at high risk of lung cancer (age 60–74 years; smoking history ≥30 pack years, current or quit within 15 years; forced expiratory volume in 1s ≥50% predicted) are recruited from the general public through newspaper advertisement and press release. Participants receive a LDCT scan of the chest at baseline, year 1 and year 2 using a multidetector helical computed tomography scanner and are followed up for a total of 5 years. Feasibility of screening will be assessed by cancer detection rates, lung nodule prevalence, optimal management strategies for lung nodules, economic costs, healthcare utilisation and participant quality of life. Conclusions Studying LDCT screening in the Australian setting will help us understand how differences in populations, background diseases and healthcare structures modulate screening effectiveness. This information, together with results from overseas randomised studies, will inform and facilitate local policymaking.